Shanghai Shunho: NGP and Industrial Hemp Strategic Layout

Business by 2FIRSTS.ai
May.11.2024
Shanghai Shunho: NGP and Industrial Hemp Strategic Layout
Shanghai Shunho New Materials Technology Co., Ltd. held its 2023 annual performance briefing, focusing on financial reports and business strategies.

On May 10, Shanghai Shunho New Materials Technology Co., Ltd. (stock abbreviation: Shunho Stock, stock code: 002565) held its 2023 annual performance briefing. The briefing was conducted through the Shenzhen Stock Exchange's "Interactive Easy" platform, and included discussions on the company's 2023 financial report, introductions to its new tobacco and industrial hemp businesses, as well as its work in environmental protection and social responsibility.

Shanghai Shunho: NGP and Industrial Hemp Strategic Layout
Shanghai Shunho New Materials Technology Co., Ltd. Investor Relations Activity Record Form | Image Source: Shunho Corporation

 

In response to the adjustment of revenue from the new tobacco business, the company explained that the data in the 2023 interim report has not been audited. During the annual report audit process, in order to more accurately reflect the essence of the new tobacco business, the company will adjust the revenue recognition method from the "gross method" to the "net method," resulting in lower annual revenue compared to the revenue disclosed in the interim report. Shunho Corporation stated that the new tobacco and industrial hemp business are strategically important for the company's business layout, and the company will rigorously and carefully manage the production and operation of these related businesses.

 

In terms of expanding into overseas markets, the company has announced that its investments in Shenzhen Meizhonglian Technology Co., Ltd. and Shenzhen Lvxinfeng Technology Co., Ltd. have obtained relevant licenses. The products they are involved in include disposable e-cigarettes, e-cigarette accessories, pods, heating tobacco products, and others, primarily exporting to countries and regions such as North America, South America, the Middle East, Southeast Asia, the European Union, the United Kingdom, and Japan. 

 

The company has expressed confidence in the future development of the e-cigarette industry, emphasizing that as the inventor and owner of core technology patents, it has been deeply involved in the new tobacco industry for many years and has established a good complementarity and synergy in its domestic and international business layout. As of now, the company's subsidiary, Shenzhen Lvxinfeng Technology Co., Ltd., has obtained the Tobacco Monopoly Production Enterprise License for e-cigarette processing enterprises, while the invested company, Shenzhen Meizhonglian Technology Co., Ltd., has obtained the Tobacco Monopoly Production Enterprise License for e-cigarette product manufacturers. The company's subsidiary, Shanghai Shunho Yilong Electronic Technology Co., Ltd., has obtained the Tobacco Monopoly Production Enterprise License for e-cigarette brand holders for domestic sales.

 

The company can engage in new tobacco business in compliance with relevant regulations in the field, gradually highlighting the company's competitive advantages in production and technology. At the same time, the company is accelerating its overseas layout, rapidly expanding its domestic and international business to form a good situation of complementary advantages in advanced technology research and development applications, resource sharing, and collaborative operations, which has been beneficial for the company and shareholders in exploring and discovering value. In the future, the company will continue to improve the layout of the new tobacco industry chain in production, branding, contract processing, and export at home and abroad, leveraging industry development opportunities, fully leveraging its brand and production processing technology advantages, and striving to secure more market share for the company.

 

In response to investors' questions about profits and research investment, the company stated that they remain optimistic about the development prospects of the biotechnology and health industry, and are closely monitoring the application and development of CBD in areas such as pharmaceuticals, pain management, mental health, health supplements, and daily chemical products.

 

The company stated that it will continue to leverage its technological and production advantages in the fields of new tobacco and industrial hemp, striving to gain more market share as the legalization of industrial hemp rapidly advances in multiple countries around the world. The global market for industrial hemp is further opening up and expanding in industrial applications. As the inventor and owner of core technology patents for new tobacco products, the company established itself early in the industry with strong technological and production advantages. In the future, the company will continuously improve its layout in the domestic and international production, branding, contract manufacturing, and export industries of new tobacco, seizing opportunities for industrial development to fully utilize its brand and production processing technology advantages, and work hard to gain more market share for the company.

 

Regarding ESG ratings, the company stated that it has always placed high importance on environmental protection and social responsibility. It has released a "Social Responsibility Report" for 11 consecutive years and has pledged to continue to focus on and enhance environmental protection and information disclosure efforts.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Indian Anti-Vape Group: Weak Enforcement of Vape Ban as Online and Black Market Sales Surge
Indian Anti-Vape Group: Weak Enforcement of Vape Ban as Online and Black Market Sales Surge
Indian medical experts and the group Mothers Against Vaping warn that e-cigarettes damage youth heart, lung, and mental health. Despite the 2019 ban, vaping products remain available via underground markets. They call on the government to tighten digital platform regulation and adopt stricter international controls.
Jul.08
Samsung Wins US E-Cigarette Battery Explosion Lawsuit; Judge Rules It Didn’t Enter Consumer Market
Samsung Wins US E-Cigarette Battery Explosion Lawsuit; Judge Rules It Didn’t Enter Consumer Market
Samsung SDI escaped liability in a U.S. lawsuit over a vape battery explosion after an appeals court ruled it had no direct ties to the consumer vape market and took steps to prevent unauthorized use of its batteries.
Jul.16 by 2FIRSTS.ai
Canadian Nicotine Alternatives Firm Delota Partners with 180 Global to Expand Eastern E-Cigarette Market
Canadian Nicotine Alternatives Firm Delota Partners with 180 Global to Expand Eastern E-Cigarette Market
Nicotine e-cigarette retailer Delota Corp. has announced a strategic partnership between its subsidiary 180 Smoke and 180 Global, securing online vaping retail rights across five eastern Canadian provinces. Under the deal, 180 Global will manage the regional brand, which may reduce Delota’s revenues and expenditures but is expected to improve profitability, highlighting its push to expand in the Canadian market.
Jul.10 by 2FIRSTS.ai
Australia's TGA reiterates: Nicotine pouches are prescription drugs in Australia, and unapproved products pose safety risks.
Australia's TGA reiterates: Nicotine pouches are prescription drugs in Australia, and unapproved products pose safety risks.
Illegal sale of nicotine pouches in Australia is on the rise, posing health risks and legal consequences.
Aug.08 by 2FIRSTS.ai
UK E-Cigarette Approved List Update: 320 New SKUs Approved, Including ELFBAR, SKE, MASKKING, and More (July 28 - August 1)
UK E-Cigarette Approved List Update: 320 New SKUs Approved, Including ELFBAR, SKE, MASKKING, and More (July 28 - August 1)
Between July 28 and August 1, the UK Medicines and Healthcare Products Regulatory Agency (MHRA) e-cigarette product notification database listed 320 new SKUs, including e-cigarettes, multi-flavor pods, and accessories from brands like ELFBAR, IVG, SKE, MASKKING, and INNOKIN.
Aug.05 by 2FIRSTS.ai
Wisconsin Set to Ban Non-FDA Approved Vapes Starting September, Court Ruling Pending
Wisconsin Set to Ban Non-FDA Approved Vapes Starting September, Court Ruling Pending
Wisconsin is planning to prohibit the sale of all vape products that have not been approved by the U.S. Food and Drug Administration (FDA) starting September 1. At present, WISCOFAST, a non-profit trade association formed by vape shop owners, has filed a lawsuit against the state government in an attempt to block the law from taking effect. The court is expected to rule later this week on whether the ban will be enforced.
Aug.27 by 2FIRSTS.ai